Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Jynneos, Injektionssuspension 20
Drug
Jynneos, Injektionssuspension
Aktive Immunisierung gegen durch Pocken-, Affenpocken- und Vacciniaviren hervorgerufene Erkrankungen
08.08. – vaccines
HAM – Human medicine
SUPAS – suspension for injection
I – vaccines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
3/1/2024
2/28/2029
Dosage strength
Jynneos, Injektionssuspension
Aktive Immunisierung gegen durch Pocken-, Affenpocken- und Vacciniaviren hervorgerufene Erkrankungen
01
Z – approved
Package
No information made available
A/NR – Authorised / not referenced
20 vial(s)
001
Z – approved
Declaration
Component
≥ 50 Mio. U. virus vaccinia Ankara modificatus vivus attenuatum
trometamolum
natrii chloridum
1.6 mg natrium
aqua ad iniectabile
natrii chloridum
1.6 mg natrium
aqua ad iniectabile
Authorisation holder
7601001410855
Bavarian Nordic Switzerland AG
Grafenauweg 8
6301 Zug (ZG)
Grafenauweg 8
6301 Zug (ZG)
Date of revision of the text
6/1/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.